Efficacy of Nissen Sleeve Gastrectomy on Mid-term Barrett's Esophagus Regression.
Bariatric metabolic surgery
Barrett’s esophagus
GERD
Gastric bypass
Nissen fundoplication
Nissen sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
06 Jan 2024
06 Jan 2024
Historique:
received:
14
06
2023
accepted:
26
12
2023
revised:
25
11
2023
medline:
7
1
2024
pubmed:
7
1
2024
entrez:
6
1
2024
Statut:
aheadofprint
Résumé
Sleeve gastrectomy is the most commonly performed bariatric operation globally. The main complication is GERD. In the medium term, it can increase the incidence of Barrett's esophagus (BE), which is a risk factor for esophageal adenocarcinoma. Following conventional sleeve gastrectomy, BE is noted in up to 16% of patients postoperatively. Recently, Nissen sleeve gastrectomy (NSG) has been shown to reduce the frequency of postoperative GERD compared to conventional sleeve gastrectomy. This study aims to evaluate the impact of NSG on the incidence and remission of BE in the long term. This bicentric retrospective study included 692 patients who received NSG from September 2013 to July 2021. All patients underwent preoperative upper GI endoscopy and were then scheduled to receive upper GI endoscopy between 1 and 2 years and then between 3 and 5 years postoperatively. BE was systematically confirmed by biopsies. Seventy-four patients had endoscopic suspicion of BE, which was confirmed on 54/692 patients by histology. The BE lesions consisted of 18.5% intestinal metaplasia and 75.9% fundal metaplasia. Among these 54 patients, 38 underwent endoscopic investigation within 2 years postoperatively. The biopsies showed healed BE in 25/38 patients (64.1%). At 5 years, two patients had proven BE. Concerning the incidence of BE post NSG: 234 performed the follow-up endoscopy within 2 years. The incidence of de novo BE is nil. The NSG is associated with healing of known BE in approximately two-thirds of patients at 2-year follow-up. This is consistent with the GERD improvement that has been shown with NSG.
Identifiants
pubmed: 38183594
doi: 10.1007/s11695-023-07034-y
pii: 10.1007/s11695-023-07034-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
English WJ, DeMaria EJ, Hutter MM, et al. American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2020;16:457–63.
doi: 10.1016/j.soard.2019.12.022
Clapp B, Ponce J, DeMaria E, et al. American Society for Metabolic and Bariatric Surgery 2020 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2022;18:1134–40.
doi: 10.1016/j.soard.2022.06.284
Lazzati A, Guy-Lachuer R, Delaunay V, et al. Bariatric surgery trends in France: 2005–2011. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2014;10:328–34.
doi: 10.1016/j.soard.2013.07.015
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319:255–65.
doi: 10.1001/jama.2017.20897
pubmed: 29340679
pmcid: 5833546
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319:241–54.
doi: 10.1001/jama.2017.20313
pubmed: 29340676
pmcid: 5833550
Nedelcu M, Noel P, Loureiro M, et al. Bariatric surgery and the mechanisms of gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A. 2020;30:907–11.
doi: 10.1089/lap.2020.0323
pubmed: 32614705
Stenard F, Iannelli A. Laparoscopic sleeve gastrectomy and gastroesophageal reflux. World J Gastroenterol. 2015;21:10348–57.
doi: 10.3748/wjg.v21.i36.10348
pubmed: 26420961
pmcid: 4579881
Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014;260:909–14 (discussion 914-915).
doi: 10.1097/SLA.0000000000000967
pubmed: 25379861
Leslie D, Wise E, Sheka A, et al. Gastroesophageal reflux disease outcomes after vertical sleeve gastrectomy and gastric bypass. Ann Surg. 2021;274:646–53.
doi: 10.1097/SLA.0000000000005061
pubmed: 34506320
Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371:836–45.
doi: 10.1056/NEJMra1314704
pubmed: 25162890
Sharma P. Barrett esophagus: a review. JAMA. 2022;328:663–71.
doi: 10.1001/jama.2022.13298
pubmed: 35972481
Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93:343-352.e2.
doi: 10.1016/j.gie.2020.08.008
pubmed: 32798535
Gagner M, Hutchinson C, Rosenthal R. Fifth International Consensus Conference: current status of sleeve gastrectomy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2016;12:750–6.
doi: 10.1016/j.soard.2016.01.022
Nocca D, Skalli EM, Boulay E, et al. Nissen sleeve (N-Sleeve) operation: preliminary results of a pilot study. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2016;12:1832–7.
doi: 10.1016/j.soard.2016.02.010
Olmi S, Cesana G, Gambioli A, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic sleeve + Rossetti fundoplication on weight loss and de novo GERD in patients affected by morbid obesity: a randomized clinical study. Obes Surg. 2022;32:1451–8.
doi: 10.1007/s11695-022-05955-8
pubmed: 35137287
pmcid: 9055016
Nocca D, Galtier F, Taleb S, et al. Peri-operative morbidity of nissen sleeve gastrectomy: prospective evaluation of a cohort of 365 patients, beyond the learning curve. Obes Surg. 2022;32:1–7.
doi: 10.1007/s11695-022-06066-0
pubmed: 35524904
Thota PN, Vennalaganti P, Vennelaganti S, et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett’s esophagus less than 1 cm (irregular Z line) within 5 years of index endoscopy. Gastroenterology. 2017;152:987–92.
doi: 10.1053/j.gastro.2016.12.005
pubmed: 27988383
Salminen P, Grönroos S, Helmiö M, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157:656–66.
doi: 10.1001/jamasurg.2022.2229
pubmed: 35731535
pmcid: 9218929
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2020;271:257–65.
doi: 10.1097/SLA.0000000000003275
pubmed: 30921053
Fisher OM, Chan DL, Talbot ML, et al. Barrett’s oesophagus and bariatric/metabolic surgery-IFSO 2020 position statement. Obes Surg. 2021;31:915–34.
doi: 10.1007/s11695-020-05143-6
pubmed: 33460005
Swei E, Helmkamp L, Samuels J, et al. Reflux and Barrett’s esophagus after sleeve gastrectomy: analysis of a statewide database. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2023;S1550–7289(23):00078–83.
Chang VC, Pan P, Shah SK, et al. Routine preoperative endoscopy in patients undergoing bariatric surgery. Surg Obes Relat Dis. 2020;16:745–50.
doi: 10.1016/j.soard.2020.02.002
pubmed: 32192865
Cheng YL, Elli EF. Management of gastric intestinal metaplasia in patients undergoing routine endoscopy before bariatric surgery. Updat Surg. 2022;74:1383–8.
doi: 10.1007/s13304-021-01181-6
Adil MT, Al-Taan O, Rashid F, et al. A systematic review and meta-analysis of the effect of Roux-en-Y gastric bypass on Barrett’s esophagus. Obes Surg. 2019;29:3712–21.
doi: 10.1007/s11695-019-04083-0
pubmed: 31309524
DeMeester TR. Surgical therapy for Barrett’s esophagus: prevention, protection and excision. Dis Esophagus Off J Int Soc Dis Esophagus. 2002;15:109–16.
doi: 10.1046/j.1442-2050.2002.00217.x
Wetscher GJ, Gadenstaetter M, Klingler PJ, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg. 2001;234:627–32.
doi: 10.1097/00000658-200111000-00007
pubmed: 11685025
pmcid: 1422086
Csendes A, Orellana O, Cuneo N, et al. Long-term (15-year) objective evaluation of 150 patients after laparoscopic Nissen fundoplication. Surgery. 2019;166:886–94.
doi: 10.1016/j.surg.2019.04.024
pubmed: 31227185
Oberg S, Johansson J, Wenner J, et al. Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery. Ann Surg. 2001;234:619–26.
doi: 10.1097/00000658-200111000-00006
pubmed: 11685024
pmcid: 1422085
Johansson J, Johnsson F, Joelsson B, et al. Outcome 5 years after 360 degree fundoplication for gastro-oesophageal reflux disease. Br J Surg. 1993;80:46–9.
doi: 10.1002/bjs.1800800118
pubmed: 8428292
Isolauri J, Luostarinen M, Viljakka M, et al. Long-term comparison of antireflux surgery versus conservative therapy for reflux esophagitis. Ann Surg. 1997;225:295–9.
doi: 10.1097/00000658-199703000-00009
pubmed: 9060586
pmcid: 1190680
Rantanen TK, Halme TV, Luostarinen ME, et al. The long term results of open antireflux surgery in a community-based health care center. Am J Gastroenterol. 1999;94:1777–81.
doi: 10.1111/j.1572-0241.1999.01205.x
pubmed: 10406234
Gutschow CA, Schröder W, Hölscher AH. Barrett’s esophagus: what is the poison - alkaline, biliary or acidic reflux? Dis Esophagus Off J Int Soc Dis Esophagus. 2002;15:5–9.
doi: 10.1046/j.1442-2050.2002.00218.x
Szachnowicz S, Duarte AF, Nasi A, et al. Laparoscopic total fundoplication is superior to medical treatment for reducing the cancer risk in Barrett’s esophagus: a long-term analysis. Dis Esophagus Off J Int Soc Dis Esophagus. 2022;35:doac026.
doi: 10.1093/dote/doac026
Wilson H, Mocanu V, Sun W, et al. Fundoplication is superior to medical therapy for Barrett’s esophagus disease regression and progression: a systematic review and meta-analysis. Surg Endosc. 2022;36:2554–63.
doi: 10.1007/s00464-021-08543-6
pubmed: 34008109
Markar SR, Arhi C, Leusink A, et al. The influence of antireflux surgery on esophageal cancer risk in England: national population-based cohort study. Ann Surg. 2018;268:861–7.
doi: 10.1097/SLA.0000000000002890
pubmed: 30048317
Parmar C, Zakeri R, Abouelazayem M, et al. Esophageal and gastric malignancies after bariatric surgery: a retrospective global study. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2022;18:464–72.
doi: 10.1016/j.soard.2021.11.024